Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001562180-21-005877
Filing Date
2021-09-08
Accepted
2021-09-08 16:15:43
Documents
2
Period of Report
2021-09-03

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 3  
1 PRIMARY DOCUMENT primarydocument.xml 3 1757
2 POA - GEORGE V. MIGAUSKY poa-migausky.txt EX-24 3364
  Complete submission text file 0001562180-21-005877.txt   6650
Mailing Address C/O DYAX CORP. 300 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address
MIGAUSKY GEORGE V (Reporting) CIK: 0001134365 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37553 | Film No.: 211242290

Mailing Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Issuer) CIK: 0001590877 (see all company filings)

EIN.: 471851754 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)